Werewolf Therapeutics adopts amended bylaws, elects directors at annual meeting

On June 12, 2025, the board of directors of Werewolf Therapeutics, Inc. (the “Company”) adopted amended and restated bylaws of the Company (as amended and restated, the “Third Amended and Restated Bylaws” ), effective immediately, in order to, among other things: (a) revise and clarify certain procedural mechanics and informational requirements in connection with stockholder nominations of directors and submissions of stockholder proposals pursuant to the advance notice provisions of the Third Amended and Restated Bylaws, including by defining certain terms and requiring such stockholder to update such notice, if necessary, so that it remains true and correct closer to the meeting date; (b) specify individuals who may preside over meetings of the Company’s stockholders; and (c) make other administrative, modernizing, clarifying and conforming changes.